Reuters - Video

Edition: US | UK | IN | CN | JP

video Breakingviews

Breakingviews TV: Array factor

Monday, June 17, 2019 - 03:31

Pfizer is buying Array BioPharma for $11 billion, a 62% premium. It’s Big Pharma buying another smallish biotech, but in this case, Array’s backstory is a mix of skill, law and luck, as Rob Cyran explains.

▲ Hide Transcript

View Transcript

Pfizer is buying Array BioPharma for $11 billion, a 62% premium. It’s Big Pharma buying another smallish biotech, but in this case, Array’s backstory is a mix of skill, law and luck, as Rob Cyran explains.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Breakingviews TV: Array factor

Monday, June 17, 2019 - 03:31